v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 5,998,928 $ 20,729,983
Accounts receivable 166,262 242,617
Prepaid expenses 828,965 521,370
Other current assets 350,927 360,125
Total Current Assets 7,345,082 21,854,095
Property and equipment, net 4,878,417 5,523,013
Operating lease right-of-use assets 512,317 549,504
Intangible assets, net 332,221 23,886
Total Assets 13,068,037 27,950,498
Current Liabilities    
Accounts payable 3,348,322 3,211,287
Accrued liabilities 3,227,595 3,928,761
Deferred revenue 22,938,400 23,000,000
Management and directors' fees payable 25,073 59,625
Current portion of long-term debt 1,043,142 1,207,007
Current portion of finance lease liabilities 47,718 48,570
Current portion of operating lease liabilities 190,099 199,323
Current portion of grant repayable 54,168 55,855
Warrant liability 101,097 126,649
Total Current Liabilities 30,975,614 31,837,077
Long-term debt, net of current portion 3,865,357 3,624,860
Finance lease liabilities, net of current portion 363,927 400,022
Operating lease liabilities, net of current portion 350,810 378,054
Grant repayable, net of current portion 409,940 422,707
Total Long-Term Liabilities 4,990,034 4,825,643
Total Liabilities 35,965,648 36,662,720
Stockholders' Deficit    
Common Stock Authorized: 100,000,000 shares of common stock, at $0.001 par value per share Issued and outstanding: 82,928,314 shares and 81,898,321 shares, respectively 82,928 81,898
Additional paid-in capital 195,755,863 194,448,414
Accumulated other comprehensive income 282,252 243,940
Accumulated deficit (217,929,441) (202,576,507)
Total VolitionRx Limited Stockholders' Deficit (21,808,398) (7,802,255)
Non-controlling interest (1,089,213) (909,967)
Total Stockholders' Deficit (22,897,611) (8,712,222)
Total Liabilities and Stockholders' Deficit $ 13,068,037 $ 27,950,498

Source

10-Q PDF
XBRL